| Class | Medicine | Available inhaler types (brand names) | TGA-approved age group | Notes |
| SABA | Salbutamol | pMDI with dose counter (Asmol, Ventolin, Zempreon) | No restriction | ≤3 years: with small spacer plus mask 4–5 years: with small spacer |
| Breath-actuated MDI (Airomir Autohaler) | No restriction | Breath-actuated MDIs not recommended for children 1–5 years | ||
| ICS | Fluticasone propionate | pMDI (Axotide Junior, Flixotide Junior) | ≥ 1 years | ≤3 years: with small spacer plus mask 4–5 years: with small spacer and mouthpiece |
| DPI (Axotide Junior Accuhaler, Flixotide Junior Accuhaler) | ≥ 5 years | DPIs not recommended for children 1–5 years ⚠ Accuhaler contradicted for children with severe milk-protein allergy | ||
| Fluticasone furoate | DPI (Arnuity Ellipta) | ≥ 5 years | DPIs not recommended for children 1–5 years ⚠ Arnuity Ellipta contradicted for children with severe milk-protein allergy | |
| ICS-LABA | Fluticasone propionate-salmeterol | pMDI (Evocair, Pavtide, Seretide) | ≥4 years | 4–5 years: with small spacer and mouthpiece |
| DPI (Pavtide Accuhaler, Seretide Accuhaler) | ≥4 years | DPIs not recommended for children 1–5 years ⚠ Accuhaler contradicted for children with severe milk-protein allergy | ||
| LABA | Salmeterol | DPI (Serevent Accuhaler)
| ≥4 years | Salmeterol indicated only in patients also using ICS or oral corticosteroids Separate inhalers for ICS and LABA should be generally avoided to prevent accidental LABA monotherapy DPIs not recommended for children 1–5 years ⚠ Accuhaler contradicted for children with severe milk-protein allergy |
Additional information
DPI; dry powder inhaler; ICS: inhaled corticosteroid; LABA: long-acting beta2 agonist; MDI: metered-dose inhaler; pMDI: pressurised metered-dose inhaler; SABA: short-acting beta2 agonist; TGA: Therapeutic Goods Administration
Table shows inhalers approved by TGA for the treatment of asthma in children 1–5 years.
[ ] Recommended options
[ ] Not recommended for most children in this age group